AdvaMed, the Medtech Association, today recommended refinements the Centers for Medicare & Medicaid Services (CMS) could make ...
October 8, 2026 - Paradromics Inc., a neurotechnology company developing high-data-rate brain-computer interfaces (BCIs) to restore and enhance human capabilities, today announced that its ...
Each MDUFA agreement is negotiated by FDA, the medtech industry, and other stakeholders. Congress receives the draft agreement and must consider and pass legislation authorizing it and send the ...
As we look ahead to the rest of 2026, the medtech industry stands at the confluence of a profound transformation where advanced technologies, patient‑centric models and global compliance frameworks ...
AdvaMed filed formal comments with the U.S. Copyright Office opposing renewal of an exemption that allows independent service organizations to circumvent access ...
Patients should not have to wait years for Medicare coverage of procedures using breakthrough medical technologies the FDA has already authorized for marketing after determining they meet applicable ...
The term Physical AI is appearing in strategy decks and conference agendas with increasing frequency. The basic idea is straightforward: rather than AI that interprets data on a screen, this is AI ...
Proposed acquisition would add NeoCast™, an investigational technology designed for controlled delivery and predictable distal penetration, to Terumo Neuro’s neurovascular portfolio. Aliso Viejo, ...
Momentum is building for The MedTech Conference, October 18–21, 2026, in Boston, and I hope you’ll join us. With AdvaMed member participation at an all-time high, expanding international engagement, ...
When you work in government affairs, it can be easy to spend a lot of time talking about policies, legislation and regulations. But behind every one of those conversations is a patient waiting for an ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results